U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
Image
Image from GeneReviews
details

Arteriohepatic dysplasia(AWS; ALGS; AHD)

MedGen UID:
39014
•Concept ID:
C0085280
•
Congenital Abnormality
Synonyms: Alagille syndrome; Cardiovertebral syndrome; Hepatofacioneurocardiovertebral syndrome; Watson-Miller syndrome
SNOMED CT: Arteriohepatic dysplasia (31742004); Alagille syndrome (31742004); Watson-Alagille syndrome (31742004)
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
•Concept ID:
C0443147
•
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
Autosomal dominant inheritance (Orphanet)
 
Related genes: NOTCH2, JAG1
 
Monarch Initiative: MONDO:0007318
OMIM®: 118450
OMIM® Phenotypic series: PS118450
Orphanet: ORPHA52

Disease characteristics

Excerpted from the GeneReview: Alagille Syndrome
Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, congenital cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, behavioral differences, splenomegaly, retinal changes, and vascular abnormalities may also occur. [from GeneReviews]
Full text of GeneReview (by section):
Summary  |  Diagnosis  |  Clinical Characteristics  |  Genetically Related (Allelic) Disorders  |  Differential Diagnosis  |  Management  |  Genetic Counseling  |  Resources  |  Molecular Genetics  |  Chapter Notes  |  References
Authors:
Nancy B Spinner  |  Kathleen M Loomes  |  Ian D Krantz, et. al.   view full author information

Additional description

From OMIM
Alagille syndrome is an autosomal dominant disorder that traditionally has been defined by a paucity of intrahepatic bile ducts, in association with 5 main clinical abnormalities: cholestasis, cardiac disease, skeletal abnormalities, ocular abnormalities, and a characteristic facial phenotype (Li et al., 1997). Cholestasis is a direct consequence of the paucity of bile ducts. About 39% of patients also have renal involvement, mainly renal dysplasia (Kamath et al., 2012). Turnpenny and Ellard (2012) reviewed the clinical features, diagnosis, pathogenesis, and genetics of Alagille syndrome. Genetic Heterogeneity of Alagille Syndrome Another form of Alagille syndrome (ALGS2; 610205) is caused by mutation in the NOTCH2 gene (600275).  http://www.omim.org/entry/118450

Professional guidelines

PubMed

Alagille syndrome: pathogenesis, diagnosis and management.
Turnpenny PD, Ellard S
Eur J Hum Genet 2012 Mar;20(3):251-7. Epub 2011 Sep 21 doi: 10.1038/ejhg.2011.181. PMID: 21934706Free PMC Article
Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis.
Whitington PF, Whitington GL
Gastroenterology 1988 Jul;95(1):130-6. doi: 10.1016/0016-5085(88)90301-0. PMID: 3371608
Arteriohepatic dysplasia. I. Pitfalls in diagnosis and management.
Markowitz J, Daum F, Kahn EI, Schneider KM, So HB, Altman RP, Aiges HW, Alperstein G, Silverberg M
Hepatology 1983 Jan-Feb;3(1):74-6. doi: 10.1002/hep.1840030112. PMID: 6822377

Curated

Clinical utility gene card for: Alagille Syndrome (ALGS).
Leonard LD, Chao G, Baker A, Loomes K, Spinner NB
Eur J Hum Genet 2014 Mar;22(3) Epub 2013 Jul 24 doi: 10.1038/ejhg.2013.140. PMID: 23881058Free PMC Article

Recent clinical studies

Etiology

Biliary atresia revisited.
Kahn E
Pediatr Dev Pathol 2004 Mar-Apr;7(2):109-24. Epub 2004 Mar 4 doi: 10.1007/s10024-003-0307-y. PMID: 14994122
Long-term complications of arteriohepatic dysplasia.
Schwarzenberg SJ, Grothe RM, Sharp HL, Snover DC, Freese D
Am J Med 1992 Aug;93(2):171-6. doi: 10.1016/0002-9343(92)90047-f. PMID: 1497013
Anthropometric evaluation of children with chronic liver disease.
Sokol RJ, Stall C
Am J Clin Nutr 1990 Aug;52(2):203-8. doi: 10.1093/ajcn/52.2.203. PMID: 2375285
Arteriohepatic dysplasia in infancy and childhood: a longitudinal study of six patients.
Dahms BB, Petrelli M, Wyllie R, Henoch MS, Halpin TC, Morrison S, Park MC, Tavill AS
Hepatology 1982 May-Jun;2(3):350-8. doi: 10.1002/hep.1840020311. PMID: 7076119
Familial intrahepatic cholestasis: an update.
Riely CA
Yale J Biol Med 1979 Jan-Feb;52(1):89-98. PMID: 452627Free PMC Article

Diagnosis

Alagille syndrome: pathogenesis, diagnosis and management.
Turnpenny PD, Ellard S
Eur J Hum Genet 2012 Mar;20(3):251-7. Epub 2011 Sep 21 doi: 10.1038/ejhg.2011.181. PMID: 21934706Free PMC Article
Biliary atresia revisited.
Kahn E
Pediatr Dev Pathol 2004 Mar-Apr;7(2):109-24. Epub 2004 Mar 4 doi: 10.1007/s10024-003-0307-y. PMID: 14994122
Alagille syndrome. The widening spectrum of arteriohepatic dysplasia.
Crosnier C, Lykavieris P, Meunier-Rotival M, Hadchouel M
Clin Liver Dis 2000 Nov;4(4):765-78. doi: 10.1016/s1089-3261(05)70140-9. PMID: 11232356
Alagille syndrome.
Krantz ID, Piccoli DA, Spinner NB
J Med Genet 1997 Feb;34(2):152-7. doi: 10.1136/jmg.34.2.152. PMID: 9039994Free PMC Article
The Alagille syndrome (arteriohepatic dysplasia).
Mueller RF
J Med Genet 1987 Oct;24(10):621-6. doi: 10.1136/jmg.24.10.621. PMID: 3119852Free PMC Article

Therapy

Unusual clinical manifestations in a case of Alagille syndrome.
Gadkari R, Doshi B, Nayak C, Ghildiyal R, Madke B, Ghia D
Pediatr Dermatol 2014 Sep-Oct;31(5):599-602. doi: 10.1111/pde.12132. PMID: 25333075
Use of ursodeoxycholic acid in the treatment of arteriohepatic dysplasia.
Kay MH, Wyllie R, Steffen RM
Clin Pediatr (Phila) 1996 Nov;35(11):593-6. doi: 10.1177/000992289603501106. PMID: 8953135
Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome).
Marino IR, ChapChap P, Esquivel CO, Zetti G, Carone E, Borland L, Tzakis AG, Todo S, Rowe MI, Starzl TE
Transpl Int 1992 May;5(2):61-4. doi: 10.1007/BF00339217. PMID: 1627241Free PMC Article
Long-term complications of arteriohepatic dysplasia.
Schwarzenberg SJ, Grothe RM, Sharp HL, Snover DC, Freese D
Am J Med 1992 Aug;93(2):171-6. doi: 10.1016/0002-9343(92)90047-f. PMID: 1497013
IgA nephritis in a patient with Alagille syndrome and a transplanted liver.
Gilboa N, Hopp L, Agostini RM
Pediatr Nephrol 1992 Nov;6(6):559-61. doi: 10.1007/BF00866506. PMID: 1482647

Prognosis

Alagille syndrome. The widening spectrum of arteriohepatic dysplasia.
Crosnier C, Lykavieris P, Meunier-Rotival M, Hadchouel M
Clin Liver Dis 2000 Nov;4(4):765-78. doi: 10.1016/s1089-3261(05)70140-9. PMID: 11232356
Arteriohepatic dysplasia (Alagille syndrome; Watson-Alagille syndrome).
MacMillan JC, Shepherd R, Heritage M
Baillieres Clin Gastroenterol 1998 Jun;12(2):275-91. doi: 10.1016/s0950-3528(98)90135-x. PMID: 9890073
Long-term complications of arteriohepatic dysplasia.
Schwarzenberg SJ, Grothe RM, Sharp HL, Snover DC, Freese D
Am J Med 1992 Aug;93(2):171-6. doi: 10.1016/0002-9343(92)90047-f. PMID: 1497013
Paucity of interlobular bile ducts. Arteriohepatic dysplasia and nonsyndromic duct paucity.
Kahn E
Perspect Pediatr Pathol 1991;14:168-215. PMID: 2038547
Nephropathy in arteriohepatic dysplasia (Alagille's syndrome).
Wolfish NM, Shanon A
Child Nephrol Urol 1988-1989;9(3):169-72. PMID: 3252966

Clinical prediction guides

The role of lipids in nephrosclerosis and glomerulosclerosis.
Gröne EF, Walli AK, Gröne HJ, Miller B, Seidel D
Atherosclerosis 1994 May;107(1):1-13. doi: 10.1016/0021-9150(94)90136-8. PMID: 7945552
Anthropometric evaluation of children with chronic liver disease.
Sokol RJ, Stall C
Am J Clin Nutr 1990 Aug;52(2):203-8. doi: 10.1093/ajcn/52.2.203. PMID: 2375285
Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia).
Habib R, Dommergues JP, Gubler MC, Hadchouel M, Gautier M, Odievre M, Alagille D
Pediatr Nephrol 1987 Jul;1(3):455-64. doi: 10.1007/BF00849254. PMID: 3153318
del(20p) with manifestations of arteriohepatic dysplasia.
Byrne JL, Harrod MJ, Friedman JM, Howard-Peebles PN
Am J Med Genet 1986 Aug;24(4):673-8. doi: 10.1002/ajmg.1320240411. PMID: 3740100
Arteriohepatic dysplasia: phenotypic features and family studies.
Mueller RF, Pagon RA, Pepin MG, Haas JE, Kawabori I, Stevenson JG, Stephan MJ, Blumhagen JD, Christie DL
Clin Genet 1984 Apr;25(4):323-31. doi: 10.1111/j.1399-0004.1984.tb01998.x. PMID: 6424981

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    Reviews

    Related information

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...